Cargando…

Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease

Alcohol-related liver disease (ALD) is a major cause of liver disease and represents a global burden, as treatment options are scarce. Whereas 90% of ethanol abusers develop alcoholic fatty liver disease (AFLD), only a minority evolves to steatohepatitis and cirrhosis. Alcohol increases lipogenesis...

Descripción completa

Detalles Bibliográficos
Autores principales: Sangineto, Moris, Grander, Christoph, Grabherr, Felix, Mayr, Lisa, Enrich, Barbara, Schwärzler, Julian, Dallio, Marcello, Bukke, Vidyasagar Naik, Moola, Archana, Moschetta, Antonio, Adolph, Timon E., Sabbà, Carlo, Serviddio, Gaetano, Tilg, Herbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255095/
https://www.ncbi.nlm.nih.gov/pubmed/35786161
http://dx.doi.org/10.1080/19490976.2022.2089006
_version_ 1784740855307829248
author Sangineto, Moris
Grander, Christoph
Grabherr, Felix
Mayr, Lisa
Enrich, Barbara
Schwärzler, Julian
Dallio, Marcello
Bukke, Vidyasagar Naik
Moola, Archana
Moschetta, Antonio
Adolph, Timon E.
Sabbà, Carlo
Serviddio, Gaetano
Tilg, Herbert
author_facet Sangineto, Moris
Grander, Christoph
Grabherr, Felix
Mayr, Lisa
Enrich, Barbara
Schwärzler, Julian
Dallio, Marcello
Bukke, Vidyasagar Naik
Moola, Archana
Moschetta, Antonio
Adolph, Timon E.
Sabbà, Carlo
Serviddio, Gaetano
Tilg, Herbert
author_sort Sangineto, Moris
collection PubMed
description Alcohol-related liver disease (ALD) is a major cause of liver disease and represents a global burden, as treatment options are scarce. Whereas 90% of ethanol abusers develop alcoholic fatty liver disease (AFLD), only a minority evolves to steatohepatitis and cirrhosis. Alcohol increases lipogenesis and suppresses lipid-oxidation implying steatosis, although the key role of intestinal barrier integrity and microbiota in ALD has recently emerged. Bacteroides thetaiotaomicron (Bt) is a prominent member of human and murine intestinal microbiota, and plays important functions in metabolism, gut immunity, and mucosal barrier. We aimed to investigate the role of Bt in the genesis of ethanol-induced liver steatosis. Bt DNA was measured in feces of wild-type mice receiving a Lieber-DeCarli diet supplemented with an increase in alcohol concentration. In a second step, ethanol-fed mice were orally treated with living Bt, followed by analysis of intestinal homeostasis and histological and biochemical alterations in the liver. Alcohol feeding reduced Bt abundance, which was preserved by Bt oral supplementation. Bt-treated mice displayed lower hepatic steatosis and triglyceride content. Bt restored mucosal barrier and reduced LPS translocation by enhancing mucus thickness and production of Mucin2. Furthermore, Bt up-regulated Glucagon-like peptide-1 (GLP-1) expression and restored ethanol-induced Fibroblast growth factor 15 (FGF15) down-regulation. Lipid metabolism was consequently affected as Bt administration reduced fatty acid synthesis (FA) and improved FA oxidation and lipid exportation. Moreover, treatment with Bt preserved the mitochondrial fitness and redox state in alcohol-fed mice. In conclusion, recovery of ethanol-induced Bt depletion by oral supplementation was associated with restored intestinal homeostasis and ameliorated experimental ALD. Bt could serve as a novel probiotic to treat ALD in the future.
format Online
Article
Text
id pubmed-9255095
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-92550952022-07-06 Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease Sangineto, Moris Grander, Christoph Grabherr, Felix Mayr, Lisa Enrich, Barbara Schwärzler, Julian Dallio, Marcello Bukke, Vidyasagar Naik Moola, Archana Moschetta, Antonio Adolph, Timon E. Sabbà, Carlo Serviddio, Gaetano Tilg, Herbert Gut Microbes Research Paper Alcohol-related liver disease (ALD) is a major cause of liver disease and represents a global burden, as treatment options are scarce. Whereas 90% of ethanol abusers develop alcoholic fatty liver disease (AFLD), only a minority evolves to steatohepatitis and cirrhosis. Alcohol increases lipogenesis and suppresses lipid-oxidation implying steatosis, although the key role of intestinal barrier integrity and microbiota in ALD has recently emerged. Bacteroides thetaiotaomicron (Bt) is a prominent member of human and murine intestinal microbiota, and plays important functions in metabolism, gut immunity, and mucosal barrier. We aimed to investigate the role of Bt in the genesis of ethanol-induced liver steatosis. Bt DNA was measured in feces of wild-type mice receiving a Lieber-DeCarli diet supplemented with an increase in alcohol concentration. In a second step, ethanol-fed mice were orally treated with living Bt, followed by analysis of intestinal homeostasis and histological and biochemical alterations in the liver. Alcohol feeding reduced Bt abundance, which was preserved by Bt oral supplementation. Bt-treated mice displayed lower hepatic steatosis and triglyceride content. Bt restored mucosal barrier and reduced LPS translocation by enhancing mucus thickness and production of Mucin2. Furthermore, Bt up-regulated Glucagon-like peptide-1 (GLP-1) expression and restored ethanol-induced Fibroblast growth factor 15 (FGF15) down-regulation. Lipid metabolism was consequently affected as Bt administration reduced fatty acid synthesis (FA) and improved FA oxidation and lipid exportation. Moreover, treatment with Bt preserved the mitochondrial fitness and redox state in alcohol-fed mice. In conclusion, recovery of ethanol-induced Bt depletion by oral supplementation was associated with restored intestinal homeostasis and ameliorated experimental ALD. Bt could serve as a novel probiotic to treat ALD in the future. Taylor & Francis 2022-07-03 /pmc/articles/PMC9255095/ /pubmed/35786161 http://dx.doi.org/10.1080/19490976.2022.2089006 Text en © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Sangineto, Moris
Grander, Christoph
Grabherr, Felix
Mayr, Lisa
Enrich, Barbara
Schwärzler, Julian
Dallio, Marcello
Bukke, Vidyasagar Naik
Moola, Archana
Moschetta, Antonio
Adolph, Timon E.
Sabbà, Carlo
Serviddio, Gaetano
Tilg, Herbert
Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease
title Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease
title_full Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease
title_fullStr Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease
title_full_unstemmed Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease
title_short Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease
title_sort recovery of bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255095/
https://www.ncbi.nlm.nih.gov/pubmed/35786161
http://dx.doi.org/10.1080/19490976.2022.2089006
work_keys_str_mv AT sanginetomoris recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease
AT granderchristoph recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease
AT grabherrfelix recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease
AT mayrlisa recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease
AT enrichbarbara recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease
AT schwarzlerjulian recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease
AT dalliomarcello recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease
AT bukkevidyasagarnaik recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease
AT moolaarchana recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease
AT moschettaantonio recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease
AT adolphtimone recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease
AT sabbacarlo recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease
AT serviddiogaetano recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease
AT tilgherbert recoveryofbacteroidesthetaiotaomicronameliorateshepaticsteatosisinexperimentalalcoholrelatedliverdisease